SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 55.69 |
| Enterprise Value ($M) | 1.71 |
| Book Value ($M) | 64.87 |
| Book Value / Share | 8.46 |
| Price / Book | 0.86 |
| NCAV ($M) | 22.13 |
| NCAV / Share | 2.88 |
| Price / NCAV | 2.52 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.22 |
| Current Ratio | 9.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 110.52 |
| Assets | 153.26 |
| Liabilities | 88.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 9.70 | 37.36 | |
| 13G | Highbridge Capital Management Llc | 5.30 | ||
| 13G/A | Tang Capital Management Llc | 8.60 | ||
| 13G/A | Perceptive Advisors Llc | 5.90 | -14.74 | |
| 13G | Aquilo Capital Management, LLC | 9.90 | ||
| 13G/A | Great Point Partners Llc | 0.00 | -100.00 | |
| 13G/A | Capital World Investors | 4.20 | -23.76 | |
| 13G | Tang Capital Partners Lp | 5.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 28,531 | 124,226 | 22.97 | |
| 25,377 | 104,125 | 24.37 | |
| 43,468 | 213,443 | 20.37 | |
| 17,320 | 66,564 | 26.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DRMA – Dermata Therapeutics, Inc. | DRRX – DURECT Corporation |
| DRUG – Bright Minds Biosciences Inc. | DWTX – Dogwood Therapeutics, Inc. |
| DYAI – Dyadic International, Inc. |
Financial data and stock pages provided by
Fintel.io